Published in BMC Med on September 04, 2012
Effectiveness of the Quotient® ADHD Assessment in a System of Care | NCT02094612
Strength-based Treatment Approach for Adults With ADHD | NCT04832737
Headache and comorbidity in children and adolescents. J Headache Pain (2013) 1.46
Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder - a systematic literature review. Neuropsychiatr Dis Treat (2014) 1.19
Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case. Eur Child Adolesc Psychiatry (2013) 1.03
Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation. Blood (2013) 0.96
A systematic review of meta-analyses of psychosocial treatment for attention-deficit/hyperactivity disorder. Clin Child Fam Psychol Rev (2015) 0.93
Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence. BMC Psychiatry (2012) 0.93
Early-life exposure to polycyclic aromatic hydrocarbons and ADHD behavior problems. PLoS One (2014) 0.90
Clinical practice: Adult attention deficit-hyperactivity disorder. N Engl J Med (2013) 0.89
The long-term outcomes of interventions for the management of attention-deficit hyperactivity disorder in children and adolescents: a systematic review of randomized controlled trials. Psychol Res Behav Manag (2013) 0.89
'Mind the gap'--mapping services for young people with ADHD transitioning from child to adult mental health services. BMC Psychiatry (2013) 0.88
Prenatal exposure to polybrominated diphenyl ethers and child attention problems at 3-7years. Neurotoxicol Teratol (2015) 0.86
Co-morbid psychiatric disorders among incarcerated ADHD populations: a meta-analysis. Psychol Med (2015) 0.84
Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)? Eur Arch Psychiatry Clin Neurosci (2014) 0.84
Effect of treatment modality on long-term outcomes in attention-deficit/hyperactivity disorder: a systematic review. PLoS One (2015) 0.83
Epidemiology of treated attention-deficit/hyperactivity disorder (ADHD) across the lifespan in Taiwan: a nationwide population-based longitudinal study. PLoS One (2014) 0.83
The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people. Philos Trans R Soc Lond B Biol Sci (2015) 0.83
Why the Diagnosis of Attention Deficit Hyperactivity Disorder Matters. Front Psychiatry (2015) 0.82
Cognitive-behavioural therapy in medication-treated adults with attention-deficit/hyperactivity disorder and co-morbid psychopathology: a randomized controlled trial using multi-level analysis. Psychol Med (2015) 0.82
Practitioner Review: Pathways to care for ADHD - a systematic review of barriers and facilitators. J Child Psychol Psychiatry (2015) 0.82
A comprehensive scoping review of ability and disability in ADHD using the International Classification of Functioning, Disability and Health-Children and Youth Version (ICF-CY). Eur Child Adolesc Psychiatry (2015) 0.82
The intraindividual impact of ADHD on the transition of adulthood to old age. Eur Arch Psychiatry Clin Neurosci (2015) 0.81
Predictors of and barriers to service use for children at risk of ADHD: longitudinal study. Eur Child Adolesc Psychiatry (2014) 0.80
Connectivity supporting attention in children with attention deficit hyperactivity disorder. Neuroimage Clin (2014) 0.79
Are there any potentially dangerous pharmacological effects of combining ADHD medication with alcohol and drugs of abuse? A systematic review of the literature. BMC Psychiatry (2015) 0.79
Sustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studies. Ther Clin Risk Manag (2013) 0.79
Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder. Neuropsychiatr Dis Treat (2015) 0.78
Childhood hyperactivity and mood problems at mid-life: evidence from a prospective birth cohort. Soc Psychiatry Psychiatr Epidemiol (2016) 0.78
Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database. J Korean Med Sci (2016) 0.78
Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom control. Neuropsychiatr Dis Treat (2017) 0.77
A longitudinal study of risk and protective factors associated with successful transition to secondary school in youth with ADHD: prospective cohort study protocol. BMC Pediatr (2016) 0.76
The impact of ADHD on the health and well-being of ADHD children and their siblings. Eur Child Adolesc Psychiatry (2016) 0.76
Early Morning Functioning in Stimulant-Treated Children and Adolescents with Attention-Deficit/Hyperactivity Disorder, and its Impact on Caregivers. J Child Adolesc Psychopharmacol (2015) 0.75
Medical treatment of children and youths with attention-deficit/hyperactivity disorder (ADHD): a Norwegian Prescription Registry Based Study. Glob J Health Sci (2014) 0.75
Attention-Deficit/Hyperactivity Disorder. Dtsch Arztebl Int (2017) 0.75
Association between societal costs and treatment response in children and adolescents with ADHD and their parents. A cross-sectional study in the Netherlands. Springerplus (2015) 0.75
Cognitive behavioral therapy for adults with attention-deficit hyperactivity disorder: study protocol for a randomized controlled trial. Trials (2015) 0.75
Attention-deficit/hyperactivity disorder severity, diagnosis, & later academic achievement in a national sample. Soc Sci Res (2016) 0.75
Impulsive Aggression as a Comorbidity of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. J Child Adolesc Psychopharmacol (2016) 0.75
Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial. BMC Psychiatry (2016) 0.75
Structural brain imaging correlates of ASD and ADHD across the lifespan: a hypothesis-generating review on developmental ASD-ADHD subtypes. J Neural Transm (Vienna) (2016) 0.75
Optimal management of ADHD in older adults. Neuropsychiatr Dis Treat (2016) 0.75
A qualitative process evaluation of a randomised controlled trial of a parenting intervention in community (school) settings for children at risk of attention deficit hyperactivity disorder (ADHD). BMC Psychiatry (2015) 0.75
Moving to Capture Children's Attention: Developing a Methodology for Measuring Visuomotor Attention. PLoS One (2016) 0.75
Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine. Patient Prefer Adherence (2016) 0.75
A randomized controlled trial reporting functional outcomes of cognitive-behavioural therapy in medication-treated adults with ADHD and comorbid psychopathology. Eur Arch Psychiatry Clin Neurosci (2016) 0.75
Psychometric properties of the Barkley Deficits in Executive Functioning Scale: A Spanish-Language Version in a community sample of puerto rican adults. Psychol Assess (2015) 0.75
Assessment of adult attention-deficit/hyperactivity disorder. J Psychiatry Neurosci (2014) 0.75
Experienced consequences of being diagnosed with ADHD as an adult - a qualitative study. BMC Psychiatry (2015) 0.75
Trend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: a nationwide survey in Taiwan. Neuropsychiatr Dis Treat (2017) 0.75
Association of attention-deficit/hyperactivity disorder with gambling disorder. J Neural Transm (Vienna) (2016) 0.75
One-year follow-up of two novel CBTs for adolescents with ADHD. Eur Child Adolesc Psychiatry (2015) 0.75
Inhibition of hyperactivity and impulsivity by carbonic anhydrase inhibitors in spontaneously hypertensive rats, an animal model of ADHD. Psychopharmacology (Berl) (2015) 0.75
The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry (2007) 14.02
A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry (1999) 13.56
The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry (2006) 11.85
The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry (2009) 6.71
Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2007) 6.57
The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med (2006) 5.56
Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics. Pediatrics (2000) 5.21
Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry (1993) 4.71
Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry (2007) 4.69
Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry (2001) 3.87
3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry (2007) 3.33
National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics (2004) 3.25
Hyperactive boys almost grown up. I. Psychiatric status. Arch Gen Psychiatry (1985) 3.00
Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study. J Abnorm Child Psychol (1995) 2.55
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry (2010) 2.53
Long-term school outcomes for children with attention-deficit/hyperactivity disorder: a population-based perspective. J Dev Behav Pediatr (2007) 2.36
Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry (1996) 2.24
Attention-deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence. J Am Acad Child Adolesc Psychiatry (2001) 2.18
Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry (1985) 2.17
National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics (2004) 2.10
Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry (2007) 1.98
Epidemiology of attention-deficit/hyperactivity disorder across the lifespan. Curr Opin Psychiatry (2007) 1.98
Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biol Psychiatry (2008) 1.82
Predictors of persistent ADHD: an 11-year follow-up study. J Psychiatr Res (2010) 1.56
Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children. J Am Acad Child Adolesc Psychiatry (1994) 1.51
Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2006) 1.46
Risky driving in adolescents and young adults with childhood ADHD. J Pediatr Psychol (2007) 1.37
Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment. BMC Psychiatry (2002) 1.35
Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry (2001) 1.25
Practitioner review: Quality of life in child mental health--conceptual challenges and practical choices. J Child Psychol Psychiatry (2009) 1.21
The stability of dimensions of behavior in ADHD and normal children over an 8-year followup. J Abnorm Child Psychol (1993) 1.21
Cognitive behaviour therapy in medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. BMC Psychiatry (2011) 1.19
The history of attention deficit hyperactivity disorder. Atten Defic Hyperact Disord (2010) 1.16
Practitioner review: Non-pharmacological treatments for ADHD: a lifespan approach. J Child Psychol Psychiatry (2009) 1.16
Young adult outcome of hyperactive children who received long-term stimulant treatment. J Am Acad Child Psychiatry (1984) 1.16
Classification of behavior disorders in adolescence: scaling methods, predictive validity, and gender differences. J Abnorm Psychol (2010) 1.15
Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic outcome. J Child Adolesc Psychopharmacol (2008) 1.15
Avoiding the 'twilight zone': recommendations for the transition of services from adolescence to adulthood for young people with ADHD. BMC Psychiatry (2011) 1.14
Is there a link between adolescent cigarette smoking and pharmacotherapy for ADHD? Psychol Addict Behav (2003) 1.04
[ADHD in adulthood--guidelines based on expert consensus with DGPPN support]. Nervenarzt (2003) 0.99
Growing out of ADHD: the relationship between functioning and symptoms. J Atten Disord (2007) 0.97
An epidemiological study of ADHD symptoms among young persons and the relationship with cigarette smoking, alcohol consumption and illicit drug use. J Child Psychol Psychiatry (2011) 0.93
Possible association between attention deficit hyperactivity disorder and attempted suicide in adolescents - a pilot study. Eur Psychiatry (2009) 0.89
The MTA at 8. J Am Acad Child Adolesc Psychiatry (2009) 0.88
Addiction in developmental perspective: influence of conduct disorder severity, subtype, and attention-deficit hyperactivity disorder on problem severity and comorbidity in adults with opioid dependence. J Addict Dis (2012) 0.87
A national epidemiological study of offending and its relationship with ADHD symptoms and associated risk factors. J Atten Disord (2012) 0.85
Long-term efficacy of ADHD pharmacotherapy in children. Pediatr Ann (2008) 0.81
Attention deficit/hyperactivity disorder: complexities and controversies. Curr Opin Pediatr (2006) 0.81
Does behavior therapy normalize the classroom behavior of hyperactive children? Arch Gen Psychiatry (1984) 0.79
A systematic review of global publication trends regarding long-term outcomes of ADHD. Front Psychiatry (2012) 0.79
Hyperkinetic adult. Study of the "paradoxical" amphetamine response. JAMA (1972) 0.79
The MTA at 8. J Am Acad Child Adolesc Psychiatry (2009) 0.78
The syndrome of minimal brain dysfunction in young adult patients. Bull Menninger Clin (1968) 0.77
Risperidone in children with autism and serious behavioral problems. N Engl J Med (2002) 9.35
The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry (2009) 6.71
Increased risk for irritable bowel syndrome after acute diverticulitis. Clin Gastroenterol Hepatol (2013) 4.24
Geographic variation in the prevalence of attention-deficit/hyperactivity disorder: the sunny perspective. Biol Psychiatry (2013) 3.47
3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry (2007) 3.33
Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry (2005) 2.94
Is ADHD a valid diagnosis in adults? Yes. BMJ (2010) 2.80
Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States. J Am Acad Child Adolesc Psychiatry (2012) 2.14
Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry (2009) 2.13
Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison. Appl Health Econ Health Policy (2012) 2.06
Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry (2007) 2.03
What aspects of peer relationships are impaired in children with attention-deficit/hyperactivity disorder? J Consult Clin Psychol (2005) 2.03
Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol (2003) 2.02
Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning. J Abnorm Child Psychol (2007) 1.98
Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry (2007) 1.98
The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatr (2012) 1.73
Risperidone and adaptive behavior in children with autism. J Am Acad Child Adolesc Psychiatry (2006) 1.71
A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2008) 1.70
Characteristics of children with elevated symptoms of mania: the Longitudinal Assessment of Manic Symptoms (LAMS) study. J Clin Psychiatry (2010) 1.67
Validity of the autism diagnostic interview-revised. Am J Ment Retard (2006) 1.66
The services for children and adolescents-parent interview: development and performance characteristics. J Am Acad Child Adolesc Psychiatry (2004) 1.64
Toward DSM-V: an item response theory analysis of the diagnostic process for DSM-IV alcohol abuse and dependence in adolescents. J Am Acad Child Adolesc Psychiatry (2008) 1.63
Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry (2006) 1.61
Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study. CNS Drugs (2013) 1.58
Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. J Am Acad Child Adolesc Psychiatry (2009) 1.55
Physical compatibility of neonatal total parenteral nutrition admixtures containing organic calcium and inorganic phosphate salts in a simulated infusion at 37 degrees C. Pediatr Crit Care Med (2009) 1.52
Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry (2007) 1.48
Longitudinal Assessment of Manic Symptoms (LAMS) study: background, design, and initial screening results. J Clin Psychiatry (2010) 1.47
Use of complementary and alternative medicine by patients with cancer in Saudi Arabia. J Altern Complement Med (2012) 1.46
Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J Autism Dev Disord (2008) 1.46
Self-perceptions of competence in children with ADHD and comparison children. J Consult Clin Psychol (2004) 1.43
Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder. J Clin Child Adolesc Psychol (2005) 1.41
Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil (2005) 1.38
Long-term risk of acute diverticulitis among patients with incidental diverticulosis found during colonoscopy. Clin Gastroenterol Hepatol (2013) 1.35
Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry (2006) 1.34
Parent-reported homework problems in the MTA study: evidence for sustained improvement with behavioral treatment. J Clin Child Adolesc Psychol (2010) 1.31
Reliability of the services for children and adolescents-parent interview. J Am Acad Child Adolesc Psychiatry (2004) 1.31
Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. J Atten Disord (2008) 1.27
Assessing Homework Problems in Children with ADHD: Validation of a Parent-Report Measure and Evaluation of Homework Performance Patterns. School Ment Health (2010) 1.27
Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. Am J Psychiatry (2005) 1.26
Acute and long-term safety and tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol (2005) 1.24
The transition to middle school is associated with changes in the developmental trajectory of ADHD symptomatology in young adolescents with ADHD. J Clin Child Adolesc Psychol (2008) 1.24
Socioeconomic status as a moderator of ADHD treatment outcomes. J Am Acad Child Adolesc Psychiatry (2002) 1.23
Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms study. J Clin Psychiatry (2012) 1.23
Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies. J Child Adolesc Psychopharmacol (2003) 1.23
The proteomics of quiescent and nonquiescent cell differentiation in yeast stationary-phase cultures. Mol Biol Cell (2011) 1.21
Patterns and predictors of adolescent academic achievement and performance in a sample of children with attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol (2011) 1.20
Cognitive behaviour therapy in medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. BMC Psychiatry (2011) 1.19
Effects of short- and long-term risperidone treatment on prolactin levels in children with autism. Biol Psychiatry (2006) 1.18
Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD. Am J Psychiatry (2012) 1.18
Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details. J Atten Disord (2008) 1.18
Genetic and environmental contributions to common psychopathologies of childhood and adolescence: a study of twins and their siblings. J Abnorm Child Psychol (2006) 1.17
Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry (2005) 1.17
Under diagnosis of adult ADHD: cultural influences and societal burden. J Atten Disord (2012) 1.17
Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data. Am J Psychiatry (2004) 1.16
Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. J Child Adolesc Psychopharmacol (2003) 1.15
Peer rejection and friendships in children with Attention-Deficit/Hyperactivity Disorder: contributions to long-term outcomes. J Abnorm Child Psychol (2012) 1.13
EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids (2003) 1.12
Time-dependent changes in positively biased self-perceptions of children with attention-deficit/hyperactivity disorder: a developmental psychopathology perspective. Dev Psychopathol (2010) 1.08
Psychopathology and comorbidity of psychiatric disorders in patients with kleptomania. Am J Psychiatry (2003) 1.06
The treatment of severe child aggression (TOSCA) study: Design challenges. Child Adolesc Psychiatry Ment Health (2011) 1.05
Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems. J Am Acad Child Adolesc Psychiatry (2011) 1.05
A review of complementary and alternative treatments for autism spectrum disorders. Autism Res Treat (2012) 1.04
A review of neurofeedback treatment for pediatric ADHD. J Atten Disord (2011) 1.03
Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case. Eur Child Adolesc Psychiatry (2013) 1.03
Feasibility of a nutritional supplement as treatment for pediatric bipolar spectrum disorders. J Altern Complement Med (2012) 1.03
Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program. Clin Ther (2012) 1.01
Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative study. Health Qual Life Outcomes (2012) 1.01
Developmental processes in peer problems of children with attention-deficit/hyperactivity disorder in the Multimodal Treatment Study of Children With ADHD: developmental cascades and vicious cycles. Dev Psychopathol (2010) 1.00
Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol Psychiatry (2007) 1.00
Dietary sensitivities and ADHD symptoms: thirty-five years of research. Clin Pediatr (Phila) (2010) 0.99
Prevalence of poor performance status in lung cancer patients: implications for research. J Thorac Oncol (2008) 0.99
The role of children's ethnicity in the relationship between teacher ratings of attention-deficit/hyperactivity disorder and observed classroom behavior. J Consult Clin Psychol (2005) 0.99
Examining predictors of reaction times in children with ADHD and normal controls. J Int Neuropsychol Soc (2009) 0.98
Evaluation of group cognitive behavioral therapy for adults with ADHD. J Atten Disord (2008) 0.97
Comparison of commissural sprouting in the mouse and rat fascia dentata after entorhinal cortex lesion. Hippocampus (2003) 0.97
Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol (2006) 0.96
A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA). Curr Psychiatry Rep (2008) 0.96
Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice. J Child Adolesc Psychopharmacol (2008) 0.96
Trial design challenges when combining medication and parent training in children with pervasive developmental disorders. J Autism Dev Disord (2008) 0.96
Treatment for ADHD: is more complex treatment cost-effective for more complex cases? Health Serv Res (2007) 0.96
The relationship between satisfaction with life, ADHD symptoms, and associated problems among university students. J Atten Disord (2008) 0.95
Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases A SPECT study with partial volume effect correction. Clin Neurol Neurosurg (2007) 0.95
Parental Agreement on ADHD Symptom-Specific and Broadband Externalizing Ratings of Child Behavior. J Emot Behav Disord (2010) 0.95
Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2010) 0.94
A prospective open trial of guanfacine in children with pervasive developmental disorders. J Child Adolesc Psychopharmacol (2006) 0.94
Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems. Child Adolesc Psychiatr Clin N Am (2014) 0.94
Bipolar and ADHD Comorbidity: Both Artifact and Outgrowth of Shared Mechanisms. Clin Psychol (New York) (2010) 0.94
Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders. Child Adolesc Psychiatr Clin N Am (2008) 0.94
Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. J Autism Dev Disord (2008) 0.94
Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. Curr Med Res Opin (2010) 0.93
An epidemiological study of ADHD symptoms among young persons and the relationship with cigarette smoking, alcohol consumption and illicit drug use. J Child Psychol Psychiatry (2011) 0.93
Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD. J Atten Disord (2008) 0.93
Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence. BMC Psychiatry (2012) 0.93
Multinutrient supplement as treatment: literature review and case report of a 12-year-old boy with bipolar disorder. J Child Adolesc Psychopharmacol (2009) 0.92
An item response theory analysis of DSM-IV conduct disorder. J Am Acad Child Adolesc Psychiatry (2009) 0.92
The decisions regarding ADHD management (DRAMa) study: uncertainties and complexities in assessment, diagnosis and treatment, from the clinician's point of view. Eur Child Adolesc Psychiatry (2011) 0.92
Conduct disorder and initiation of substance use: a prospective longitudinal study. J Am Acad Child Adolesc Psychiatry (2013) 0.91